ABOUT AVIDITY

Our mission is to profoundly improve people’s lives by delivering a new class of RNA therapeutics – AOCs. Our proprietary AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics. Our advancing and expanding pipeline includes multiple skeletal muscle programs. We are also broadening the reach of AOCs beyond muscle tissues through both internal discovery efforts and key partnerships as the company continues to deliver on the RNA revolution.

Learn More

SEC Filings

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQRNA
FormDescriptionDateFormat
D/AAmendment to a previously filed Form DFebruary 18, 2014Open Amendment to a previously filed Form D in HTML.Open Amendment to a previously filed Form D in DOC file.Open Amendment to a previously filed Form D in PDF file.Open Amendment to a previously filed Form D in XLS file.
DOfficial notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the ActFebruary 15, 2014Open Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act in HTML.Open Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act in DOC file.Open Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act in PDF file.Open Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act in XLS file.